Language Selection


Molecular Detection by RT-PCR

<<Return to Laboratory

Requisition Forms

Reference Details


Molecular detection of hepatitis C virus by in house real-time (RT)-PCR targeting two regions of the viral genome (5’ UTR and 3’ UTR).

Test Category:
Molecular Detection
Hepatitis C virus (HCV)
Illnesses and Diseases:
  • Hepatitis C

Serum or plasma sample. Minimum volume required for serum or plasma – 1.0 mL.

Collection Method:

Collect blood in serum separator tubes (SST) or EDTA tubes.

Specimen Processing, Storage and Shipping:

Store samples frozen until shipped for testing. Ship frozen on dry ice.

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.


Patient Criteria:

Suspected hepatitis C infection.  Serology results must show markers to the hepatitis C virus.

Accompanying Documentation:

Completed Viral Hepatitis and Bloodborne Pathogens requisition including sender name, address and telephone number.  Patient name or identifier (referring specimen lab #), date of birth, suspected exposure, test(s) requested.  Type of specimen and date collected.  If possible, include the clinical history and lab results that have already been done at local or provincial laboratories. Where known, please include the viral load.  



Methods and Interpretation of Results:

Real Time (RT) and conventional PCR with multiple Taqman primer sets.

Turnaround Time:

19 calendar days.

Phone #: (204) 789-5063
Fax: (204) 789-2018
  1. J. Garson. The polymerase chain reaction and hepatitis C virus diagnosis. FEMS Microbiology Reviews, 1994, 14; 229-240.
  2. Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.Transfusion. 2005; 45:1258-66.
Related Information: